| J0897 | Injection, denosumab, 1 mg | 9,960 | $20 | $189.2K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,900 | $30 | $132.6K |
| J3262 | Injection, tocilizumab, 1 mg | 30,640 | $1 | $122.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,230 | $30 | $84K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20,000 | $1 | $80K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 680 | $100 | $66.7K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,750 | $10 | $63.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $110 | $23K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 270 | $60 | $16.8K |
| J7326 | Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 40 | $410 | $15.4K |